The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling

Alessio Reggio, Filomena Spada, Marco Rosina, Giorgia Massacci, Alessandro Zuccotti, Claudia Fuoco, Cesare Gargioli, Luisa Castagnoli, Gianni Cesareni

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Fibro/Adipogenic Progenitors (FAPs) define a stem cell population playing a pro-regenerative role after muscle damage. When removed from their natural niche, FAPs readily differentiate into adipocytes or fibroblasts. This digressive differentiation potential, which is kept under tight control in the healthy muscle niche, contributes to fat and scar infiltrations in degenerative myopathies, such as in Duchenne Muscular Dystrophy (DMD). Controlling FAP differentiation by means of small molecules may contribute to delay the adverse consequences of the progressive pathological degeneration while offering, at the same time, a wider temporal window for gene therapy and cell-based strategies. In a high content phenotypic screening, we identified the immunosuppressant, azathioprine (AZA) as a negative modulator of FAP adipogenesis. We show here that AZA negatively affects the adipogenic propensity of FAPs purified from wild type and mdx mice by impairing the expression of the master adipogenic regulator, peroxisome proliferator-activated receptor γ (PPARγ). We show that this inhibition correlates with a decline in the activation of the AKT-mTOR axis, the main pathway that transduces the pro-adipogenic stimulus triggered by insulin. In addition, AZA exerts a cytostatic effect that has a negative impact on the mitotic clonal process that is required for the terminal differentiation of the preadipocyte-committed cells.

Original languageEnglish
Article number4360
JournalScientific Reports
Volume9
Issue number1
DOIs
Publication statusPublished - Dec 1 2019

Fingerprint

Adipogenesis
Azathioprine
Immunosuppressive Agents
Muscles
Pharmaceutical Preparations
Inbred mdx Mouse
Peroxisome Proliferator-Activated Receptors
Duchenne Muscular Dystrophy
Cytostatic Agents
Muscular Diseases
Adipocytes
Genetic Therapy
Cicatrix
Stem Cells
Fibroblasts
Fats
Insulin
Population

ASJC Scopus subject areas

  • General

Cite this

The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling. / Reggio, Alessio; Spada, Filomena; Rosina, Marco; Massacci, Giorgia; Zuccotti, Alessandro; Fuoco, Claudia; Gargioli, Cesare; Castagnoli, Luisa; Cesareni, Gianni.

In: Scientific Reports, Vol. 9, No. 1, 4360, 01.12.2019.

Research output: Contribution to journalArticle

Reggio, Alessio ; Spada, Filomena ; Rosina, Marco ; Massacci, Giorgia ; Zuccotti, Alessandro ; Fuoco, Claudia ; Gargioli, Cesare ; Castagnoli, Luisa ; Cesareni, Gianni. / The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling. In: Scientific Reports. 2019 ; Vol. 9, No. 1.
@article{a1e936750faa4c8bb0a7060f22c58099,
title = "The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling",
abstract = "Fibro/Adipogenic Progenitors (FAPs) define a stem cell population playing a pro-regenerative role after muscle damage. When removed from their natural niche, FAPs readily differentiate into adipocytes or fibroblasts. This digressive differentiation potential, which is kept under tight control in the healthy muscle niche, contributes to fat and scar infiltrations in degenerative myopathies, such as in Duchenne Muscular Dystrophy (DMD). Controlling FAP differentiation by means of small molecules may contribute to delay the adverse consequences of the progressive pathological degeneration while offering, at the same time, a wider temporal window for gene therapy and cell-based strategies. In a high content phenotypic screening, we identified the immunosuppressant, azathioprine (AZA) as a negative modulator of FAP adipogenesis. We show here that AZA negatively affects the adipogenic propensity of FAPs purified from wild type and mdx mice by impairing the expression of the master adipogenic regulator, peroxisome proliferator-activated receptor γ (PPARγ). We show that this inhibition correlates with a decline in the activation of the AKT-mTOR axis, the main pathway that transduces the pro-adipogenic stimulus triggered by insulin. In addition, AZA exerts a cytostatic effect that has a negative impact on the mitotic clonal process that is required for the terminal differentiation of the preadipocyte-committed cells.",
author = "Alessio Reggio and Filomena Spada and Marco Rosina and Giorgia Massacci and Alessandro Zuccotti and Claudia Fuoco and Cesare Gargioli and Luisa Castagnoli and Gianni Cesareni",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-39538-y",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling

AU - Reggio, Alessio

AU - Spada, Filomena

AU - Rosina, Marco

AU - Massacci, Giorgia

AU - Zuccotti, Alessandro

AU - Fuoco, Claudia

AU - Gargioli, Cesare

AU - Castagnoli, Luisa

AU - Cesareni, Gianni

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Fibro/Adipogenic Progenitors (FAPs) define a stem cell population playing a pro-regenerative role after muscle damage. When removed from their natural niche, FAPs readily differentiate into adipocytes or fibroblasts. This digressive differentiation potential, which is kept under tight control in the healthy muscle niche, contributes to fat and scar infiltrations in degenerative myopathies, such as in Duchenne Muscular Dystrophy (DMD). Controlling FAP differentiation by means of small molecules may contribute to delay the adverse consequences of the progressive pathological degeneration while offering, at the same time, a wider temporal window for gene therapy and cell-based strategies. In a high content phenotypic screening, we identified the immunosuppressant, azathioprine (AZA) as a negative modulator of FAP adipogenesis. We show here that AZA negatively affects the adipogenic propensity of FAPs purified from wild type and mdx mice by impairing the expression of the master adipogenic regulator, peroxisome proliferator-activated receptor γ (PPARγ). We show that this inhibition correlates with a decline in the activation of the AKT-mTOR axis, the main pathway that transduces the pro-adipogenic stimulus triggered by insulin. In addition, AZA exerts a cytostatic effect that has a negative impact on the mitotic clonal process that is required for the terminal differentiation of the preadipocyte-committed cells.

AB - Fibro/Adipogenic Progenitors (FAPs) define a stem cell population playing a pro-regenerative role after muscle damage. When removed from their natural niche, FAPs readily differentiate into adipocytes or fibroblasts. This digressive differentiation potential, which is kept under tight control in the healthy muscle niche, contributes to fat and scar infiltrations in degenerative myopathies, such as in Duchenne Muscular Dystrophy (DMD). Controlling FAP differentiation by means of small molecules may contribute to delay the adverse consequences of the progressive pathological degeneration while offering, at the same time, a wider temporal window for gene therapy and cell-based strategies. In a high content phenotypic screening, we identified the immunosuppressant, azathioprine (AZA) as a negative modulator of FAP adipogenesis. We show here that AZA negatively affects the adipogenic propensity of FAPs purified from wild type and mdx mice by impairing the expression of the master adipogenic regulator, peroxisome proliferator-activated receptor γ (PPARγ). We show that this inhibition correlates with a decline in the activation of the AKT-mTOR axis, the main pathway that transduces the pro-adipogenic stimulus triggered by insulin. In addition, AZA exerts a cytostatic effect that has a negative impact on the mitotic clonal process that is required for the terminal differentiation of the preadipocyte-committed cells.

UR - http://www.scopus.com/inward/record.url?scp=85062828536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062828536&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-39538-y

DO - 10.1038/s41598-019-39538-y

M3 - Article

C2 - 30867438

AN - SCOPUS:85062828536

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 4360

ER -